RLE benefits most eyes

Article

In most eyes, the benefits of refractive lens exchange (RLE) outweigh the risks and it can provide a large improvement in patient quality of life, David Hardten said.

In most eyes, the benefits of refractive lens exchange (RLE) outweigh the risks and it can provide a large improvement in patient quality of life, David Hardten said.

"One patient told me 'This surgery has had a more positive impact on my quality of life than anything I've ever done for myself'. That's how big a difference it can make," Dr Hardten remarked.

Dr Hardten noted that quality of life metrics can be hard to establish. "There are no quality of life surveys specifically for refractive lens exchange, but some other studies show that there is a link between improved vision and quality of life."

He cited a Quality of Life Impact of Refractive Correction (QIRC) Questionnaire paper that showed lower satisfaction in patients in contact lenses and glasses than refractive surgery (Pesudovs, et al., JRS 2006;22:19).

Another survey using the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument found that emmetropes experienced the greatest quality of life, post-refractive patients came second, while those using presbyopic glasses had the least quality of life (Hays, et al., Ophth. 2003;110:2292).

Dr Hardten remarked that RLE provided many advantages over alternative refractive solutions. He noted that, with glasses there was a higher incidence of re-do's, while contact lenses had a higher incidence of re-fits. There were higher complications with radial keratotomy (RK), automated lamellar keratoplasty (ALK), LASIK, photorefractive keratectomy (PRK).

But with RLE people with reduced vision experience less handicap because there is less handicap because of less dependence on glasses and contact lenses, there is less magnification or minification of images than spectacles, and the risks associated with contact lenses are minimized.

Furthermore, there's no risk of future cataract development and there are a large variety of RLE IOLs available to today's surgeon, including monofocal, aspheric, monovision and presbyopic.

"You also get high quality outcomes," he concluded.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.